Sponsor

University of Michigan Rogel Cancer Center

Clinical research sponsor

Published trials106
Recruiting shown13
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate CancerNCT06616155 · lead sponsor · 2026-06-01
RECRUITING
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS TrialNCT07443943 · lead sponsor · 2026-04-22
RECRUITING
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialNCT07158021 · lead sponsor · 2026-01-22
RECRUITING
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer PatientsNCT07291414 · lead sponsor · 2026-01-09
RECRUITING
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) TherapyNCT07096999 · lead sponsor · 2025-01-23
RECRUITING
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast CancerNCT06915168 · lead sponsor · 2024-11-13
RECRUITING
Gilteritinib for the Treatment of ALK NSCLCNCT06225427 · lead sponsor · 2024-07-25
RECRUITING
Breast Cancer Resiliency Through Exercise Program (B-REP)NCT06100263 · lead sponsor · 2024-05-28
RECRUITING
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast CancerNCT05996107 · lead sponsor · 2024-02-27
RECRUITING
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic ProbeNCT05965180 · lead sponsor · 2023-10-16
RECRUITING
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With CancerNCT05183126 · lead sponsor · 2022-03-28
RECRUITING
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])NCT05038332 · lead sponsor · 2021-11-12
RECRUITING
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNCT07645391 · lead sponsor · 2017-01-01
RECRUITING
Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE TrialNCT07526545 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerNCT07682649 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American FamiliesNCT07542405 · lead sponsor · 2026-06-15
NOT_YET_RECRUITING
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT TrialNCT06617455 · lead sponsor · 2024-10-31
TERMINATED
Multicenter Trial of ESK981 in Patients With Select Solid TumorsNCT05988918 · lead sponsor · 2024-04-19
ACTIVE_NOT_RECRUITING
Cardiac Rehabilitation to Improve Breast Cancer OutcomesNCT05867667 · lead sponsor · 2024-03-19
TERMINATED
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast CancerNCT06228768 · lead sponsor · 2024-03-06
COMPLETED
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot StudyNCT05764005 · lead sponsor · 2022-11-09
COMPLETED
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision AidNCT05140252 · lead sponsor · 2022-05-12
COMPLETED
Michigan Genetic Hereditary Testing (MiGHT)NCT05162846 · lead sponsor · 2022-04-21
COMPLETED
Developing a Psychosexual Educational Partners Program: PEPP A Feasibility StudyNCT05070299 · lead sponsor · 2022-03-15
COMPLETED
An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer SurvivorsNCT05030792 · lead sponsor · 2021-10-26
COMPLETED
Lighting Intervention for Cancer-related FatigueNCT04827446 · lead sponsor · 2021-07-15
COMPLETED
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)NCT04748042 · lead sponsor · 2021-05-28
ACTIVE_NOT_RECRUITING
Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate CancerNCT04848337 · lead sponsor · 2021-05-25
ACTIVE_NOT_RECRUITING
Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer SurvivorsNCT04827459 · lead sponsor · 2021-05-12
COMPLETED
Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated ArthralgiasNCT04754399 · lead sponsor · 2021-04-16
COMPLETED
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerNCT04703920 · lead sponsor · 2021-03-04
COMPLETED
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate CancerNCT04194554 · lead sponsor · 2020-11-06
ACTIVE_NOT_RECRUITING
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerNCT04396808 · lead sponsor · 2020-11-05
ACTIVE_NOT_RECRUITING
Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate CancerNCT04272645 · lead sponsor · 2020-10-01
WITHDRAWN
Testing the Effect of Mindfulness for Prostatectomy OutcomesNCT04727710 · lead sponsor · 2020-08-26
TERMINATED
Altering Lipids for Tolerance of Aromatase Inhibitor TherapyNCT04268134 · lead sponsor · 2020-07-28
COMPLETED
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)NCT03787680 · lead sponsor · 2019-10-31
ACTIVE_NOT_RECRUITING
ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate CancerNCT03300505 · lead sponsor · 2019-05-31
TERMINATED
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung CancerNCT03559049 · lead sponsor · 2018-12-24
TERMINATED
Immunotherapy in Patients With Metastatic Cancers and CDK12 MutationsNCT03570619 · lead sponsor · 2018-12-14
COMPLETED
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)NCT03556904 · lead sponsor · 2018-12-10
COMPLETED
Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate CancerNCT03689582 · lead sponsor · 2018-11-13
TERMINATED
The ConnectedCancerCare Pilot Study (CCC)NCT03618017 · lead sponsor · 2018-08-08
COMPLETED
Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung CancerNCT03228186 · lead sponsor · 2018-03-05
TERMINATED
Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted AgentsNCT03242915 · lead sponsor · 2017-10-03
COMPLETED
Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to TrastuzumabNCT03135171 · lead sponsor · 2017-07-26
COMPLETED
Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate CancerNCT02946008 · lead sponsor · 2017-03-27
COMPLETED
Functional Imaging in Lung SBRTNCT03121300 · lead sponsor · 2017-02-06
COMPLETED
Genomics in Michigan Impacting Observation or RadiationNCT02783950 · lead sponsor · 2017-01-17
COMPLETED
Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast CancerNCT02712437 · lead sponsor · 2016-03-16
TERMINATED
Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell TransplantNCT02734797 · lead sponsor · 2016-03-09
COMPLETED
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung CancerNCT02492867 · lead sponsor · 2016-01-14
COMPLETED
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLCNCT02463994 · lead sponsor · 2015-10-01
COMPLETED
Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver MutationsNCT02277457 · lead sponsor · 2015-09-01
WITHDRAWN
Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast RadiotherapyNCT02494453 · lead sponsor · 2015-06-01
COMPLETED
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)NCT02400190 · lead sponsor · 2015-05-27
ACTIVE_NOT_RECRUITING
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate CancerNCT02059213 · lead sponsor · 2014-06-01
COMPLETED
Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer PatientsNCT02338115 · lead sponsor · 2014-05-01
COMPLETED
Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic PainNCT01912612 · lead sponsor · 2013-10-30
COMPLETED
Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast CancerNCT01975597 · lead sponsor · 2013-08-01
TERMINATED

Sponsor roles

lead sponsor103
collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.